And concomitant symptoms associated with migraine attack such as fatigue, poor concentration, anxiety, irritability, irritability, tearing, photophobia, phonophobia, vertigo, dizziness, neck pain, etc. Since these mined signals are associated with the indication of the anti-CGRP mAbs or symptoms accompanied by migraine, it is impossible to determine whether the drugs caused them or whether the drugs exacerbated the symptoms. Here, CALCA is linked to migraine disorder.